iKang Healthcare Group prices IPO at $14, the high end of the range

Comment

Shutterstock photo

iKang Healthcare Group, China's largest private operator of medical exam and disease screening centers, raised $153 million by offering 10.9 million shares (31% insider) at $14, the high end of the range of $12 to $14. iKang Healthcare Group plans to list on the NASDAQ under the symbol KANG. iKang Healthcare Group initially filed confidentially on 12/4/2013. BofA Merrill Lynch and UBS Investment Bank acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs


More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com